reviewNew England Journal of MedicineOct 21, 2009Closed access

Atypical Hemolytic–Uremic Syndrome

Mario Negri Institute for Pharmacological Research

PubMed
Indexed incrossrefpubmed

Abstract

The hemolytic–uremic syndrome, which is characterized by nonimmune hemolytic anemia, thrombocytopenia, and renal impairment, occurs most frequently in young children. Most cases are secondary to infection with Escherichia coli O157:H7 and other Shiga-toxin–producing strains. However, approximately 10% of cases are atypical and not associated with infection. This article reviews current concepts about the pathobiology of atypical hemolytic–uremic syndrome and its diagnosis and management.

Citation impact

1,322
total citations
FWCI
25.57
Percentile
100%
References
159
Citations per year

Authors

2

Topics & keywords

Keywords
  • Hemolytic anemia
  • Shiga toxin
  • Atypical hemolytic uremic syndrome
  • Medicine
  • Escherichia coli
  • Immunology
  • Microbiology
  • Biology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.